Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Table 5 Incidences of auras that were followed by headache prior to galcanezumab treatment

^avisual aura was determined when participants described experiencing zigzag lines, scintillation, scintillating scotoma, hemianopsia, fortification spectra, flickering lights, flashes of bright light, blind spots, c-shaped zigzag lines – All at least 20 min before onset of headache
^bSensory aura was determined when participants described experiencing tingling, numbness, or paresthesia in their fingers, hands, face, or legs
^cSpeech aura was determined when participants described having trouble with word-finding difficulty or speech production

ISSN: 1129-2377